Skip to content

Urgent urology symptoms What to do

Amgen’s Xgeva delays prostate cancer bone pain

Urology TodayPublished May 17, 20112 min read

Key points

  • A clinical trial of Amgen Inc’s bone drug, Xgeva, found that it can significantly delay the time it takes for prostate cancer to cause bone pain—a finding the company believes will help boost the drug’s market potential.
  • But the trial did not demonstrate a survival advantage (it was not designed to do so) and investors have been eager to see the full safety results.
  • Amgen also reported on Tuesday at a meeting of the American Urological Association that a cumulative 4.6 percent of denosumab patients were diagnosed with osteonecrosis of the jaw, or death of jawbone tissue.
  • Baynes also said the rates of new malignancies were similar in both arms of the trial.

A clinical trial of Amgen Inc’s bone drug, Xgeva, found that it can significantly delay the time it takes for prostate cancer to cause bone pain—a finding the company believes will help boost the drug’s market potential.

Amgen said in December that monthly injections of Xgeva, also known as denosumab, added 4.2 months, compared with placebo injections, to the length of time patients lived without their cancer spreading.

But the trial did not demonstrate a survival advantage (it was not designed to do so) and investors have been eager to see the full safety results.

“We saw a 33 percent reduction in the risk of developing symptoms of bone metastases, mainly pain” said Roy Baynes, Amgen’s vice president of global development.

Amgen also reported on Tuesday at a meeting of the American Urological Association that a cumulative 4.6 percent of denosumab patients were diagnosed with osteonecrosis of the jaw, or death of jawbone tissue.

Baynes said the rates of ONJ seen in the trial—1.1 percent at year one, 2.9 percent at year two and 4.2 percent at year three—were consistent with those seen in earlier trials of the drug in patients with advanced cancer.

“ONJ is generally readily manageable,” he said.

Baynes also said the rates of new malignancies were similar in both arms of the trial. Treatment with denosumab was associated with a higher risk of hypocalcemia, or too little calcium in the blood.

The Xgeva trial involved 1,432 men with prostate cancer who had stopped responding to hormone therapy.

A separate pivotal trial presented at the urological meeting showed that denosumab significantly delayed worsening of pain in prostate cancer patients compared with Novartis AG’s Zometa.

Analysts, on average, have forecast annual denosumab sales of $2.5 billion by 2015, according to Thomson Pharma.

The drug is currently approved as a treatment for reducing fractures and other bone problems in certain cancer patients. It is also sold under the brand name Prolia as a treatment for osteoporosis.

###

By Deena Beasley

LOS ANGELES

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If you cannot pass urine, have a fever with back or side pain, or sudden severe pain in the testicle, call 911 or go to an emergency department.

Urinary symptoms?

Weak stream, urgency, up at night? Score it in two minutes.

Seven questions from the International Prostate Symptom Score show whether symptoms are mild, moderate or severe, and when to see a doctor.

Take the symptom score

When to get help

Most urology problems can wait for an appointment. These can’t.

Call 911 or go to an emergency department if you have any of these:

  • You cannot pass urine at allAcute urinary retention: a painful, swollen bladder. It needs a catheter, often within hours.
  • Fever or chills with back or side painA blocked, infected kidney (for example behind a stone) can turn into sepsis quickly.
  • Sudden, severe pain in a testiclePossible testicular torsion. The testicle can often be saved only within about 6 hours.
  • An erection lasting over 4 hoursPriapism. Without treatment it can cause permanent damage.
Call 911

Outside the US, call your local emergency number.

See a doctor within days

  1. 01Blood in your urineEven once, and even without pain. Usually harmless, but it is the most common first sign of bladder and kidney cancer.
  2. 02Burning, frequent or cloudy urineTypical of a urinary tract infection, which usually clears with treatment.
  3. 03A lump or swelling in a testicleMost lumps are benign; testicular cancer is very treatable when found early.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.